Stelios Papadopoulos
Director at Exelixis; Director at Biogen; Director at Ovid Therapeutics. Based in Alameda, California.
- Rank
- 1638th of 14,644
- Companies held
- 3
- Largest holding
- EXEL, 88.8% of total
- Latest SEC filing
- May 27, 2026
What the $88.8M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Exelixis EXEL Common Stock | Directly | 1,197,595 | $65.83 | $78.8M | 88.8% | Form 4, May 27, 2026 |
| Biogen BIIB Common Stock | Stelios Holdings, LLC | 17,375 | $247.13 | $4.3M | 4.8% | Form 4, Jun 15, 2022 |
| Biogen BIIB Common Stock | Esperanza Holdings, LLC | 10,831 | $247.13 | $2.7M | 3.0% | Form 4, Jun 15, 2022 |
| Biogen BIIB Common Stock | Directly | 10,095 | $247.13 | $2.5M | 2.8% | Form 4, Jun 15, 2022 |
| Ovid Therapeutics OVID Common Stock | Directly | 217,578 | $2.34 | $509K | 0.6% | Form 4, Apr 7, 2026 |
Share counts are the amounts Stelios Papadopoulos reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1635 | Navdeep Sooch Director, Silicon Laboratories. Austin, TX | $89.0M |
| 1636 | Jeffrey B. Butler Director, Privia Health Group. Arlington, VA | $88.9M |
| 1637 | Dale Francescon Executive Chairman, Century Communities. Greenwood Villiage, CO | $88.8M |
| 1638 | Stelios Papadopoulos Director, Exelixis. Alameda, CA | $88.8M |
| 1639 | Nicholas J. Deiuliis Director, CNX Resources. Canonsburg, PA | $88.8M |
| 1640 | Josef Parvizi Director, CeriBell. Sunnyvale, CA | $88.7M |
| 1641 | Brian K. McCarthy Pres.,Global Sales & Field Ops, Rubrik. Palo Alto, CA | $88.5M |
Other Exelixis insiders
All EXEL insiders- Michael Morrissey$347MPresident and CEO. #615 overall
- Christopher J. Senner$62.9MEVP and CFO. #2162 overall
- Jeffrey Hessekiel$45.7MEVP & General Counsel. #2526 overall
- Dana Aftab$39.5MEVP, Research and Development. #3042 overall
- Amy C. Peterson$30.6MEVP Prod Dev & Med Aff & CMO. #3705 overall
- Peter Lamb$28.2MEVP, Scientific Strategy & CSO. #3983 overall
Questions
How much stock does Stelios Papadopoulos own?
Stelios Papadopoulos holds $88,812,137 in listed stock based on SEC filings and current prices, mostly Exelixis (EXEL). That ranks 1638th on the Stock Rich List.
Is this Stelios Papadopoulos's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Stelios Papadopoulos last buy or sell stock?
The most recent open-market trade on file is a sale of 100,000 EXEL shares on Nov 12, 2025 at $43.55.